NantHealth, Inc. (NHIQ)

NantHealth Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Revenue	67	62.65	73.17	77.43	89.46
Revenue Growth (YoY)	6.95%	-14.38%	-5.50%	-13.45%	3.22%
Cost of Revenue	28.84	27.81	29.23	34.14	44.27
Gross Profit	38.16	34.84	43.95	43.29	45.2
Selling, General & Admin	62.5	52.09	48.53	55.6	70.76
Research & Development	23.05	19.71	17.27	13.93	20.92
Other Operating Expenses	3.94	3.94	4.41	8.19	4.22
Operating Expenses	89.49	75.74	70.21	77.72	95.9
Operating Income	-51.33	-40.9	-26.27	-34.43	-50.7
Interest Expense / Income	14.12	14.48	19.2	18.04	17.12
Other Expense / Income	2.65	2.78	10.41	11.31	128
Pretax Income	-68.1	-58.16	-55.88	-63.78	-195.83
Income Tax	-0.32	0.1	0.45	-1.02	-3.67
Net Income	-67.78	-58.26	-56.33	-62.76	-192.15
Shares Outstanding (Basic)	8	8	7	7	7
Shares Outstanding (Diluted)	8	8	7	7	7
Shares Change	1.22%	2.87%	0.55%	1.08%	-6.48%
EPS (Basic)	-8.80	-7.66	-7.65	-8.55	-26.40
EPS (Diluted)	-8.80	-7.66	-7.65	-8.55	-26.40
Free Cash Flow	-38.74	-32.77	-22.53	-13.36	-40.18
Free Cash Flow Per Share	-5.03	-4.31	-3.04	-1.81	-5.52
Gross Margin	56.96%	55.61%	60.06%	55.91%	50.52%
Operating Margin	-76.61%	-65.28%	-35.90%	-44.47%	-56.67%
Profit Margin	-101.16%	-92.99%	-76.98%	-81.06%	-214.78%
Free Cash Flow Margin	-57.81%	-52.31%	-30.78%	-17.25%	-44.91%
EBITDA	-37.99	-27.96	-19.91	-23.37	-156.35
EBITDA Margin	-56.69%	-44.63%	-27.21%	-30.19%	-174.76%
Depreciation & Amortization	15.99	15.72	16.77	22.36	22.36
EBIT	-53.98	-43.68	-36.68	-45.74	-178.71
EBIT Margin	-80.56%	-69.72%	-50.13%	-59.07%	-199.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).